A detailed history of Axxcess Wealth Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Axxcess Wealth Management, LLC holds 22,780 shares of LLY stock, worth $17 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares
22,780
Previous 21,864 4.19%
Holding current value
$17 Million
Previous $19.8 Million 1.95%
% of portfolio
0.52%
Previous 0.55%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$772.14 - $960.02 $707,280 - $879,378
916 Added 4.19%
22,780 $20.2 Million
Q2 2024

Aug 09, 2024

SELL
$724.87 - $909.04 $2.03 Million - $2.54 Million
-2,794 Reduced 11.33%
21,864 $19.8 Million
Q1 2024

May 14, 2024

BUY
$592.2 - $792.28 $580,948 - $777,226
981 Added 4.14%
24,658 $19.2 Million
Q4 2023

Feb 06, 2024

BUY
$525.19 - $619.13 $1.45 Million - $1.71 Million
2,761 Added 13.2%
23,677 $13.8 Million
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $4.9 Million - $6.76 Million
11,279 Added 117.04%
20,916 $11.2 Million
Q2 2023

Aug 08, 2023

SELL
$350.74 - $468.98 $1.45 Million - $1.93 Million
-4,124 Reduced 29.97%
9,637 $4.52 Million
Q1 2023

May 03, 2023

SELL
$310.63 - $364.82 $2.05 Million - $2.41 Million
-6,613 Reduced 32.46%
13,761 $4.73 Million
Q4 2022

Feb 14, 2023

BUY
$321.55 - $374.67 $13,826 - $16,110
43 Added 0.21%
20,374 $7.45 Million
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $2.76 Million - $3.14 Million
9,300 Added 84.31%
20,331 $6.57 Million
Q2 2022

Aug 11, 2022

BUY
$278.73 - $327.27 $754,522 - $885,919
2,707 Added 32.52%
11,031 $3.58 Million
Q1 2022

Aug 11, 2022

BUY
$234.69 - $291.66 $301,107 - $374,199
1,283 Added 18.22%
8,324 $2.38 Million
Q4 2021

Aug 11, 2022

BUY
$224.85 - $279.04 $1.58 Million - $1.96 Million
7,041 New
7,041 $1.95 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $709B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Axxcess Wealth Management, LLC Portfolio

Follow Axxcess Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axxcess Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Axxcess Wealth Management, LLC with notifications on news.